-
1 Comment
Sumitomo Dainippon Pharma Co., Ltd is currently in a long term uptrend where the price is trading 41.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Sumitomo Dainippon Pharma Co., Ltd's total revenue rose by 5.4% to $133B since the same quarter in the previous year.
Its net income has increased by 141.5% to $33B since the same quarter in the previous year.
Finally, its free cash flow grew by 2252.5% to $80B since the same quarter in the previous year.
Based on the above factors, Sumitomo Dainippon Pharma Co., Ltd gets an overall score of 5/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | F |
| CurrencyCode | EUR |
| ISIN | JP3495000006 |
| Sector | Healthcare |
| Market Cap | 2B |
|---|---|
| PE Ratio | 17.86 |
| Target Price | None |
| Beta | 0.56 |
| Dividend Yield | None |
Sumitomo Pharma Co., Ltd. engages in manufacture, and purchase and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. Further, the company offers veterinary drugs, medical devices, etc. It has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for DPM.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
